---
figid: PMC5452924__ol-13-06-4571-g01
figtitle: Operating mode of the E-cadherin-catenin complex in tumor metastasis
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC5452924
filename: ol-13-06-4571-g01.jpg
figlink: /pmc/articles/PMC5452924/figure/f2-ol-0-0-6063/
number: F2
caption: Operating mode of the E-cadherin-catenin complex in tumor metastasis. Stimulation
  of EGFR and c-Met receptors led to the translocation of ß-catenin into the cytosolic
  pool where it can be degraded. If the Wnt1 pathway is activated at the same time
  as the other two pathways, the degradation of ß-catenin is inhibited and it is translocated
  to the nucleus to combine with LEF/TCF, causing transcription of the cyclin D1 gene
  and downregulation of the CDH1 gene. Reversal by way of contact inhibition is poorly
  understood. E-CAD, E-cadherin; EGF, epidermal growth factor; EGFR, epidermal growth
  factor receptor; HGF, hepatocyte growth factor; c-Met, hepatocyte growth factor
  receptor; GAP, GTPase activating protein; β, β-catenin; α, α-catenin; IQGAP1, IQ
  motif-containing GTPase activating protein 1; GDP, guanosine diphosphate; GSK3β,
  glycogen synthase kinase 3β; APC, adenomatosis polyposis coli Wnt signaling pathway
  regulator; P, phosphorylation group; Dsh, disheveled; LEF/TCF, lymphoid enhancer
  factor/T-cell factor family of transcription factors; CDH1, cadherin 1 (E-cadherin
  gene); p27Kip1, cyclin-dependent kinase inhibitor 1B.
papertitle: 'E-cadherin: A potential biomarker of colorectal cancer prognosis.'
reftext: Niki Christou, et al. Oncol Lett. 2017 Jun;13(6):4571-4576.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.932058
figid_alias: PMC5452924__F2
figtype: Figure
redirect_from: /figures/PMC5452924__F2
ndex: c9759fca-df09-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5452924__ol-13-06-4571-g01.html
  '@type': Dataset
  description: Operating mode of the E-cadherin-catenin complex in tumor metastasis.
    Stimulation of EGFR and c-Met receptors led to the translocation of ß-catenin
    into the cytosolic pool where it can be degraded. If the Wnt1 pathway is activated
    at the same time as the other two pathways, the degradation of ß-catenin is inhibited
    and it is translocated to the nucleus to combine with LEF/TCF, causing transcription
    of the cyclin D1 gene and downregulation of the CDH1 gene. Reversal by way of
    contact inhibition is poorly understood. E-CAD, E-cadherin; EGF, epidermal growth
    factor; EGFR, epidermal growth factor receptor; HGF, hepatocyte growth factor;
    c-Met, hepatocyte growth factor receptor; GAP, GTPase activating protein; β, β-catenin;
    α, α-catenin; IQGAP1, IQ motif-containing GTPase activating protein 1; GDP, guanosine
    diphosphate; GSK3β, glycogen synthase kinase 3β; APC, adenomatosis polyposis coli
    Wnt signaling pathway regulator; P, phosphorylation group; Dsh, disheveled; LEF/TCF,
    lymphoid enhancer factor/T-cell factor family of transcription factors; CDH1,
    cadherin 1 (E-cadherin gene); p27Kip1, cyclin-dependent kinase inhibitor 1B.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egf
  - Hgf
  - Wnt1
  - Egfr
  - Rasa1
  - Brd8
  - Ctnnd1
  - Gsk3b
  - Iqgap1
  - Apc
  - Ccnd1
  - Cdh1
  - Fzr1
  - Cdkn1b
  - Ctnnb1
  - EGF
  - HGF
  - IL6
  - SOS1
  - WNT1
  - EGFR
  - MET
  - RASA1
  - RGS6
  - CTNND1
  - IGSF1
  - NOP2
  - TRPA1
  - BRD8
  - NSUN5
  - CDH1
  - GSK3B
  - IQGAP1
  - APC
  - PROC
  - HNF4A
  - CCND1
  - FZR1
  - CDKN1B
  - CTNNB1
  - Met
  - Rap1gap
  - Racgap1
  - egf
  - celsr1a
  - wnt1
  - kita
  - ngfra
  - egfra
  - met
  - gap43
  - gsk3ba
  - iqgap1
  - apc
  - gdf5
  - elk4
  - tmub2
  - nedd8
  - ccnd1
  - cdh1
  - si:busm1-180o5.1
  - si:busm1-180o5.2
  - ctnnb1
  - Cancer
---
